Slide 1

The project

The HERMIONE project enabled the early development of an anti-Netrin-1 mAb, a promising anti-cancer drug candidate.

Potential impact

On patients and their quality of life, on public health, on Science, on European biotechnology research.

The objective

The objective of the current HERMIONE-2MAN project is to conduct a first-in-man clinical trial with a first-in-class bio-therapeutic agen.


Achievements of HERMIONE-2MAN project

The HERMIONE-2MAN project will pave the way to an outstanding & innovative approach of cancer treatment, offering great clinical and market potential.